JP2023516235A5 - - Google Patents
Info
- Publication number
- JP2023516235A5 JP2023516235A5 JP2022529942A JP2022529942A JP2023516235A5 JP 2023516235 A5 JP2023516235 A5 JP 2023516235A5 JP 2022529942 A JP2022529942 A JP 2022529942A JP 2022529942 A JP2022529942 A JP 2022529942A JP 2023516235 A5 JP2023516235 A5 JP 2023516235A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- oxo
- decane
- diazaspiro
- cyclopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962943099P | 2019-12-03 | 2019-12-03 | |
| US62/943,099 | 2019-12-03 | ||
| PCT/US2020/062890 WO2021113362A1 (en) | 2019-12-03 | 2020-12-02 | Sstr5 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516235A JP2023516235A (ja) | 2023-04-19 |
| JP2023516235A5 true JP2023516235A5 (cg-RX-API-DMAC7.html) | 2023-12-08 |
Family
ID=76221934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529942A Pending JP2023516235A (ja) | 2019-12-03 | 2020-12-02 | Sstr5アンタゴニスト |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20230041621A1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4073075A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023516235A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115380036A (cg-RX-API-DMAC7.html) |
| AR (1) | AR120652A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020398874A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163243A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202134248A (cg-RX-API-DMAC7.html) |
| UY (1) | UY38976A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2021113363A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ,インク. | Gpr119アゴニスト |
| MX2022010548A (es) | 2020-02-28 | 2022-09-23 | Kallyope Inc | Agonistas de gpr40. |
| CA3227879A1 (en) * | 2021-07-30 | 2023-02-02 | TAE Life Sciences | Borylated amino acid compositions comprising bts and bts(ome) for use in boron neutron capture therapy and methods thereof |
| CN116789570B (zh) * | 2022-03-14 | 2026-01-27 | 长沙理工大学 | 磺酰胺脱氨制备磺酸衍生物的方法 |
| WO2024204277A1 (ja) | 2023-03-27 | 2024-10-03 | 株式会社スコヒアファーマ | 成長ホルモン分泌促進剤 |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| TW202606664A (zh) * | 2024-04-19 | 2026-02-16 | 美商美國禮來大藥廠 | 升糖素受體促效劑及其作為療法之用途 |
| WO2025222000A1 (en) * | 2024-04-19 | 2025-10-23 | Eli Lilly And Company | Substituted 1,1'-biphenyl compounds as glucagon receptor agonists |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0214967A (pt) * | 2001-12-14 | 2005-05-10 | Novo Nordisk As | Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente |
| ATE521610T1 (de) * | 2003-09-10 | 2011-09-15 | Virochem Pharma Inc | Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität |
| US7709642B2 (en) * | 2004-06-25 | 2010-05-04 | Virochem Pharma, Inc. | Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| CA2615656A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| KR101117931B1 (ko) * | 2006-08-15 | 2012-04-12 | 에프. 호프만-라 로슈 아게 | 페닐, 피리딘 및 퀴놀린 유도체 |
| WO2008030412A2 (en) * | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| TW201006816A (en) * | 2008-05-15 | 2010-02-16 | Organon Nv | Hexafluoroisopropanol derivatives |
| WO2010129729A1 (en) * | 2009-05-07 | 2010-11-11 | Merck Sharp & Dohme Corp. | Substituted spirocyclic amines useful as antidiabetic compounds |
| WO2011142359A1 (ja) * | 2010-05-10 | 2011-11-17 | 日産化学工業株式会社 | スピロ化合物及びアディポネクチン受容体活性化薬 |
| JP2013529210A (ja) * | 2010-05-18 | 2013-07-18 | メルク・シャープ・エンド・ドーム・コーポレイション | Sstr5アンタゴニストとしてのスピロイソオキサゾリン化合物 |
| US8742110B2 (en) * | 2010-08-18 | 2014-06-03 | Merck Sharp & Dohme Corp. | Spiroxazolidinone compounds |
| TW201712012A (zh) * | 2015-06-16 | 2017-04-01 | 美國禮來大藥廠 | 2-側氧基-1,3,8-三氮雜螺[4.5]癸-3-基羧酸衍生物 |
| WO2018024602A1 (en) * | 2016-08-04 | 2018-02-08 | Bayer Aktiengesellschaft | 2,7-diazaspiro[4.4]nonanes |
-
2020
- 2020-12-02 EP EP20896919.6A patent/EP4073075A4/en not_active Withdrawn
- 2020-12-02 CN CN202080095492.0A patent/CN115380036A/zh active Pending
- 2020-12-02 CA CA3163243A patent/CA3163243A1/en active Pending
- 2020-12-02 AU AU2020398874A patent/AU2020398874A1/en not_active Abandoned
- 2020-12-02 EP EP20895270.5A patent/EP4069708A4/en not_active Withdrawn
- 2020-12-02 WO PCT/US2020/062891 patent/WO2021113363A1/en not_active Ceased
- 2020-12-02 WO PCT/US2020/062898 patent/WO2021113368A1/en not_active Ceased
- 2020-12-02 JP JP2022529942A patent/JP2023516235A/ja active Pending
- 2020-12-02 US US17/782,361 patent/US20230041621A1/en not_active Abandoned
- 2020-12-02 UY UY0001038976A patent/UY38976A/es not_active Application Discontinuation
- 2020-12-02 EP EP20895271.3A patent/EP4069702A4/en not_active Withdrawn
- 2020-12-02 WO PCT/US2020/062890 patent/WO2021113362A1/en not_active Ceased
- 2020-12-02 US US17/782,438 patent/US20230113609A1/en not_active Abandoned
- 2020-12-02 AR ARP200103345A patent/AR120652A1/es unknown
- 2020-12-02 US US17/782,370 patent/US20230050965A1/en not_active Abandoned
- 2020-12-03 TW TW109142680A patent/TW202134248A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130261108A1 (en) | Compositions and methods for modulating farnesoid x receptors | |
| JP2022512482A5 (cg-RX-API-DMAC7.html) | ||
| JP5788507B2 (ja) | 置換3−フェニル−1,2,4−オキサジアゾール化合物 | |
| CN103502226B (zh) | 用于cetp抑制剂的环烯基芳基衍生物 | |
| US20140039007A1 (en) | Compositions and methods for modulating farnesoid x receptors | |
| CN103237795B (zh) | 经取代的噁二唑化合物及其作为s1p1激动剂的用途 | |
| EA030430B1 (ru) | Композиции и способы модуляции фарнезоидных х-рецепторов | |
| EP2001844A2 (en) | Bicyclic carboxylic acid derivatives useful for treating metabolic disorders | |
| JP2007502264A5 (cg-RX-API-DMAC7.html) | ||
| KR20150046090A (ko) | 설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도 | |
| TW200831511A (en) | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme | |
| TW200804266A (en) | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | |
| CN111164072A (zh) | β-羟基杂环胺及其在治疗高糖血症中的用途 | |
| CN103298807A (zh) | 作为用于治疗自身免疫性疾病和血管疾病的s1p1激动剂的杂环化合物 | |
| JP2004269469A (ja) | ピリミジン誘導体又はその塩 | |
| DK2697219T3 (en) | NEW PIPERIDINYLMONOCARBOXYLSYRER AS S1P1 receptor agonists | |
| RU2627361C2 (ru) | Биарил- или гетероциклические биарилзамещенные производные циклогексена в качестве ингибиторов сетр | |
| JPWO2001036402A1 (ja) | 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体 | |
| JP2020521775A5 (cg-RX-API-DMAC7.html) | ||
| JP2022542613A (ja) | ヒトatglの阻害剤 | |
| TW202417426A (zh) | 三氮唑類化合物及其作為lpar1拮抗劑的用途 | |
| CN103958484B (zh) | 噁唑烷酮类衍生物、其制备方法及其在医药上的应用 | |
| JPH08325264A (ja) | 新規2−芳香環置換−3−フェニルプロピオン酸またはアクリル酸誘導体 | |
| CN111138422B (zh) | 一种用于防治红斑狼疮的药物及其制备方法 | |
| JP2012006869A (ja) | ピリミジノン化合物およびその医薬用途 |